Bright Minds Biosciences Inc (DRUG) — Net Asset Momentum
Bright Minds Biosciences Inc (DRUG) recorded a net asset momentum of 1381.9% as of September 2025, with net assets of $82.04 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Bright Minds Biosciences Inc net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Bright Minds Biosciences Inc Net Asset Momentum (2019–2025)
This chart tracks Bright Minds Biosciences Inc's year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +1381.9%, with net assets of $82.04 Million USD as of September 2025. Check Bright Minds Biosciences Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for Bright Minds Biosciences Inc (2019–2025)
The table below shows the complete annual net asset history for Bright Minds Biosciences Inc from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see DRUG market cap.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $82.04 Million | $84.42 Million | $2.38 Million | ▲ +1381.9% |
| 2024 | $5.54 Million | $6.10 Million | $568.26K | ▼ -16.1% |
| 2023 | $6.60 Million | $6.88 Million | $280.86K | ▼ -37.4% |
| 2022 | $10.54 Million | $12.09 Million | $1.54 Million | ▼ -45.7% |
| 2021 | $19.40 Million | $20.04 Million | $638.57K | ▲ +2560.4% |
| 2020 | $729.29K | $880.22K | $150.92K | ▲ +473.1% |
| 2019 | $127.26K | $163.97K | $36.71K | — |